Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | APLNR | P35414 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 5/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.34 |
| ▸ | GBA1 | P04062 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6562561 | 0.97 | EPHX2 (0.37) | EPHX2APLNRESR1ESR2GBA1 | |
| SCHEMBL674422 | 0.93 | ESR1 (0.39) | EPHX2APLNRESR1ESR2GBA1 | |
| SCHEMBL63504 | 0.93 | ESR1 (0.39) | EPHX2APLNRESR1ESR2GBA1 | |
| SCHEMBL674423 | 0.93 | ESR1 (0.39) | EPHX2APLNRESR1ESR2GBA1 | |
| SCHEMBL44806 | 0.93 | ESR1 (0.39) | EPHX2APLNRESR1ESR2GBA1 | |
| SCHEMBL1895624 | 0.88 | ESR2 (0.45) | EPHX2APLNRESR1ESR2CYP3A4 | |
| SCHEMBL8173891 | 0.87 | TDP1 (0.39) | EPHX2ESR1ESR2GBA1CYP3A4 | |
| SCHEMBL5625 | 0.86 | — | — | |
| SCHEMBL23136777 | 0.86 | — | — | |
| SCHEMBL52490 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1240140-B1 | METHOD FOR THE PRODUCTION OF N-ALKENYL AMIDES | BASF AG (DE) | 2004-03-17 | — | — | EP | disclosed |
| US-6673920-B2 | REACTING AMIDES WITH ACETYLENES IN THE LIQUID PHASE IN THE PRESENCE OF BASIC ALKALI METAL COMPOUNDS AND OF A COCATALYST, WHICH COMPRISES USING AS THE COCATALYST DIOLS TO PREPARE N-ALKENYL-AMIDE | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-06 | — | — | US | disclosed |
| US-20030036659-A1 | Method for the production of n-alkenyl amides | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-20 | — | — | US | disclosed |
| EP-0245864-A2 | Cyclohexanedimethanol/diamine mixtures as RIM extenders | THE DOW CHEMICAL COMPANY (US) | 1987-11-19 | — | — | EP | disclosed |
| US-4659747-A | HEAT RESISTANCE | THE DOW CHEMICAL COMPANY (US) | 1987-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030036659-A1 | Method for the production of n-alkenyl amides | NAT1, SAT1, AGPAT2 | EPHX2 1288/4885APLNR 1911/4885ESR1 3675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.